dydrogesterone has been researched along with Polycystic Ovarian Syndrome in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (12.50) | 29.6817 |
2010's | 2 (25.00) | 24.3611 |
2020's | 1 (12.50) | 2.80 |
Authors | Studies |
---|---|
Cai, R; Gao, H; Huang, J; Kuang, Y; Lin, J; Lu, X; Xie, Q; Zhu, J | 1 |
Gode, F; Gurbuz, AS | 1 |
El-Shamy, ES; Hamza, H; Rezk, M | 1 |
de Araújo, CH; dos Reis, RM; Ferriani, RA; Filho, FM; Martins, Wde P; Nastri, CO | 1 |
Fujimoto, S; Ichinoe, K; Sakuragi, N; Tanaka, T | 1 |
Fujimoto, S; Kutsuzawa, T; Tanaka, T | 1 |
Rönnberg, L; Ruokonen, A; Ylöstalo, P | 1 |
Jaffe, RB; Midgley, AR | 1 |
1 review(s) available for dydrogesterone and Polycystic Ovarian Syndrome
Article | Year |
---|---|
Current status of human gonadotropin radioimmunoassay.
Topics: Chorionic Gonadotropin; Clomiphene; Dimethisterone; Dydrogesterone; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Intrauterine Devices; Luteinizing Hormone; Male; Menstruation; Norethindrone; Ovulation; Polycystic Ovary Syndrome; Pregnanediol; Radioimmunoassay | 1969 |
1 trial(s) available for dydrogesterone and Polycystic Ovarian Syndrome
Article | Year |
---|---|
Endometrial preparation for in vitro oocyte maturation: early use of estrogen increases endometrial tissue and requires lower daily dosage: a cross over trial in 'mock' cycles.
Topics: Arteries; Cross-Over Studies; Dydrogesterone; Endometrium; Estradiol; Female; Humans; Ovarian Follicle; Polycystic Ovary Syndrome; Sperm Injections, Intracytoplasmic; Ultrasonography; Uterus | 2006 |
6 other study(ies) available for dydrogesterone and Polycystic Ovarian Syndrome
Article | Year |
---|---|
Progestin-Primed Ovarian Stimulation with Dydrogesterone versus Medroxyprogesterone Acetate in Women with Polycystic Ovarian Syndrome for in vitro Fertilization: A Retrospective Cohort Study.
Topics: Adult; Cohort Studies; Dydrogesterone; Female; Fertility Agents, Female; Fertilization in Vitro; Humans; Medroxyprogesterone Acetate; Ovulation Induction; Polycystic Ovary Syndrome; Progestins; Retrospective Studies; Young Adult | 2019 |
Dydrogesterone-primed ovarian stimulation is an effective alternative to gonadotropin-releasing hormone antagonist protocol for freeze-all cycles in polycystic ovary syndrome.
Topics: Dydrogesterone; Female; Fertilization in Vitro; Gonadotropin-Releasing Hormone; Humans; Ovulation Induction; Polycystic Ovary Syndrome; Pregnancy; Pregnancy Rate; Retrospective Studies | 2020 |
Luteal support with vaginal dydrogesterone increases pregnancy rate in patients with clomifene resistant polycystic ovary syndrome receiving letrozole for ovulation induction.
Topics: Administration, Intravaginal; Adult; Clomiphene; Dydrogesterone; Female; Fertility Agents, Female; Humans; Infertility, Female; Letrozole; Ovulation Induction; Polycystic Ovary Syndrome; Pregnancy; Pregnancy Rate; Progestins; Prospective Studies; Treatment Outcome; Young Adult | 2019 |
Atypical basal body temperature (BBT) associated with ovulation after dydrogesterone administration in patients with polycystic ovarian disease.
Topics: Adult; Body Temperature; Dydrogesterone; Female; Humans; Ovulation; Polycystic Ovary Syndrome | 1984 |
The effect of ovarian wedge resection and incision on circulating gonadotropin in patients with polycystic ovarian disease.
Topics: 17-Ketosteroids; Administration, Oral; Adult; Body Temperature; Dydrogesterone; Estradiol; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Methods; Ovary; Ovulation Induction; Polycystic Ovary Syndrome; Progesterone | 1978 |
Hormonal parameters and conception rate during five different types of treatment of polycystic ovarian syndrome.
Topics: Adult; Clomiphene; Dydrogesterone; Estradiol; Estrogens; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Ovary; Polycystic Ovary Syndrome; Pregnancy; Progestins; Prospective Studies; Testosterone | 1985 |